Here are five points:
1. Mr. Lucera will take over as CFO on Aug. 29.
2. He will work out of the company’s Shrewsbury, Mass., office.
3. Mr. Lucera will oversee the Valeritas’ capital-efficient commercial strategy.
4. He has more than 20 years of experience in biotechnology, specialty pharmaceutical and medical technology companies.
5. Mr. Lucera previously served as CFO of Canada-based Viventia Bio.
More articles on quality & infection control:
Antibiotic-resistant infections cost $20B annually & 5 more statistics
AmSurg centers participate in ASC Quality Measures
Study: Viruses striking in the morning are 10x more successful in infecting
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
